Luskin A, Griffin NM, Wagele-Steffen A, et al. Decreased exacerbations and hospitalizations in adolescents enrolled in PROSPERO (Prospective Observational Study to Evaluate Predictors of Clinical Effectiveness in Response to Omalizumab). ATS 2017, abstract A5104.
E-nose in ontwikkeling voor CF- en PCD-patiënten thuis
jun 2021 | Bacteriële infecties, CF